FIELD: medicine.
SUBSTANCE: invention relates to medicine and concerns liquid water pharmaceutical compositions containing factor VII polypeptides and a stabilising agent, a method for producing and applying such compositions as well as a container for such a composition and application of such composition for treatment of factor VII dependent syndrome.
EFFECT: invention ensures production of liquid water pharmaceutical composition containing factor VII polypeptide with decreased formation of chemical and/or physical degradation products, such as products of fermentative degradation or autocatalysis.
24 cl, 8 ex, 10 tbl
Authors
Dates
2010-05-10—Published
2004-08-12—Filed